{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:47:56Z","timestamp":1787064476624,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"am","delay-in-days":297,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"National Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2016YFC1306900"],"award-info":[{"award-number":["2016YFC1306900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571310"],"award-info":[{"award-number":["81571310"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630033"],"award-info":[{"award-number":["81630033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471363"],"award-info":[{"award-number":["81471363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2015071"],"award-info":[{"award-number":["A2015071"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313809"],"award-info":[{"award-number":["2017A030313809"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.pnpbp.2018.04.004","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T12:52:46Z","timestamp":1523969566000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels"],"prefix":"10.1016","volume":"85","author":[{"given":"Lulu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rengrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2018.04.004_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0304-3940(99)00545-5","article-title":"Evidence for activation of microglia in patients with psychiatric illnesses","volume":"271","author":"Bayer","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/glia.20459","article-title":"Microglial control of neuronal death and synaptic properties","volume":"55","author":"Bessis","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0015","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1189\/jlb.0212100","article-title":"The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes","volume":"92","author":"Beumer","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomized double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1590\/S0100-879X2009001100002","article-title":"Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizophrenia: an update","volume":"42","author":"Chaves","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2147\/NDT.S43404","article-title":"Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options","volume":"10","author":"Chue","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0045","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0050","first-page":"1","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"24","author":"Drexhage","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11920-010-0148-0","article-title":"Assessment of pharmacotherapy for negative symptoms of schizophrenia","volume":"12","author":"Elizabeth","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0060","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbi.2009.10.002","article-title":"Sustained hippocampal IL-1beta over expression impairs contextual and spatial memory in transgenic mice","volume":"24","author":"Hein","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0070","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/cercor\/bhr229","article-title":"Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex","volume":"22","author":"Hinwood","year":"2012","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0920-9964(94)90081-7","article-title":"Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders","volume":"12","author":"Katila","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0080","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.psychres.2013.12.051","article-title":"Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study","volume":"215","author":"Khodaie-Ardakani","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF02980066","article-title":"Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells","volume":"27","author":"Kim","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2007.03.080","article-title":"Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia","volume":"1154","author":"Levkovitz","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0095","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2014.01.011","article-title":"Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial","volume":"153","author":"Liu","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0125","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1523\/JNEUROSCI.15-03-02097.1995","article-title":"Cerebellar toxicity of phencyclidine","volume":"15","author":"Nakki","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/exnr.1996.0022","article-title":"Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation","volume":"137","author":"Nakki","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11064-006-9162-3","article-title":"Possible mechanisms of neurodegeneration in schizophrenia","volume":"31","author":"Perez-Neri","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/appi.ajp.159.2.227","article-title":"A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography","volume":"159","author":"Potkin","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.schres.2010.09.023","article-title":"Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS","volume":"126","author":"Rabany","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnen\/59.2.137","article-title":"Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics","volume":"59","author":"Radewicz","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug na\u00efve, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","article-title":"Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization","volume":"112","author":"Steiner","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide","volume":"42","author":"Steiner","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2012.11.001","article-title":"Roles of glial cells in schizophrenia: possible targets for therapeutic approaches","volume":"53","author":"Takahashi","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0920-9964(00)00007-4","article-title":"Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients","volume":"47","author":"Theodoropoulou","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/glia.22372","article-title":"Microglia as modulators of cognition and neuropsychiatric disorders","volume":"61","author":"Thomas","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0190","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1523\/JNEUROSCI.4158-11.2011","article-title":"The role of microglia in the healthy brain","volume":"31","author":"Tremblay","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0195","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"Van Berckel","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0200","first-page":"81","article-title":"Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics","volume":"43","author":"Wierzba-Bobrowicz","year":"2005","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0205","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1523\/JNEUROSCI.0450-11.2011","article-title":"\u03b2-adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat","volume":"31","author":"Wohleb","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0210","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2147\/NDT.S64236","article-title":"Profile of minocycline and its potential in the treatment of schizophrenia","volume":"10","author":"Zhang","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0215","first-page":"1","article-title":"The importance of early identification and treatment in negative symptoms of schizophrenia","volume":"48","author":"Zhao","year":"2015","journal-title":"Chin. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.04.004_bb0220","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbi.2014.01.017","article-title":"Neonatal intrahippocampal injection of lipopolysaccharide induces deficits in social behavior and prepulse inhibition and microglial activation in rats: implication for a new schizophrenia animal model","volume":"38","author":"Zhu","year":"2014","journal-title":"Brain Behav. Immun."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618300344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618300344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:44:14Z","timestamp":1759520654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618300344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":44,"alternative-id":["S0278584618300344"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.04.004","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minocycline adjunctive treatment to risperidone for negative symptoms in schizophrenia: Association with pro-inflammatory cytokine levels","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}